AstraZeneca’s Experimental Drug Doubles Median Survival in Advanced Stomach Cancer Trial
ISLAMABAD: (News Desk) - AstraZeneca’s experimental cancer drug sonesitatug vedotin, also known as sone-ve, helped patients with advanced stomach cancer live longer than those receiving standard chemotherapy, according to late-stage…